Epigenetic reader domain inhibitor I-BRD9, Purity ≥98%

Cat. No.: X24-05-ZQ459

Epigenetic reader domain inhibitor I-BRD9, Purity ≥98%

Synonym: 1714146-59-4; GSK602; Epigenetic reader domain inhibitor

  • CAS Number: 1714146-59-4
  • Compound CID: 91668541
Product Size
5 mg; 10 mg; 25 mg
Price
Datasheet
MSDS
Properties
Description
I-BRD9, soluble in DMSO and insoluble in ethanol and water, disrupts the function of proteins that recognize and bind specific epigenetic marks, affecting the interpretation of epigenetic signals. It targets BRD4 and BRD9.
Molecular Weight
497.55
Molecular Formula
C22H22F3N3O3S2
Targets
BRD4: 5.3 (pIC50); BRD9: 7.3(pIC50)
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 94 mg/mL (188.92 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
I-BRD9 is used to investigate the role of the BRD9 bromodomain in gene regulation and chromatin remodeling.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.